Atlas Trials

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

Clinical trial NCT07559396 · RECRUITING

Trial details

NCT number
NCT07559396
Sponsor
Incyte Corporation
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2026-05-29
Primary completion
2027-01-04
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.